BR BH CHRAA 8TH) AFZER- AAS UALR FRGRREROMRE RAE RES OTT MAL MTC) ED (A) ik # B.N 4 () APE — TER | AE 1.25 D> AM 2 BIEL F 1 ~ HOWL» HALLER TIT « LF FIP AR BAe We IE BY BF 2 weft OK OR MEF RAM = DBM HED RIS 2 ARATIRSE ( Janeway's spot) HRI FARA? WR (DLR RE PIB (yi Rain t Od Biie 3 A TERUT A AMSG + RBA RA ATHOLL > 5 FMbeL My o ZUR EEA A OSPR > DORE BEA » Rn © HORE ¢ (NgOee BCT ELE (Bip AR IC hg i BS DG ME 4 ARR EER A) BAF ae > BAT MEH RL WAR SR (Bi XA (CORR DRA OA GARR S ANGMGEWG Cerebral concussion )» AME RB RAM MIERE : (AE REE RH BB ABV 6 BSE FTE RE OY Se A (COh He BIBLE AB aE Oy A (ORE aA CCT) Ay ete, 6 MK Wilson Rik» FAM EHD? (MHZ Kayser - Fleischer ring RHHM (MALE MRRRAR AHR (OF. D- Penicilianine Mi (DI FERA ES AEA A AT 7 POUR RE TER ( Pseudocyt OZR HRA? AVA RD AB 1 Et NE He 1B) ce BRS 2% 1950 FEL HG APY ED OF BMG RK Ke eA DF SAAS Le 8 LB AVATAR DEER BERD ( Anei-HBs BMEMUER CLINE ( Anti-RBe PREC RAR FT BARI NIBH BF AR ARR (WEB MET A (ORES BEART He (0) anti-Hbs SABRES DF RAMEE REC Duke ) PM + SAME Ce NLA IRA» RG (AVA BR (Bi BR Ock OD & NO UNCER + T SUR UL Ts RD (a) A BA a EH LE IT SM BS RE > UARMERBRRSRR ORRB SALMA RE MEARE (DOPE BR wih SDH IRE > ES PCRS Ba Ne BRM IY MEF > TAR AAI Doxorubicin AIRE : ae SOY (BRE (OWA st OLR Ete 12 RRR > FRED ARR? CAR HE PI GHES 4 fh 52% fe RAE ¢ Achlohydria ) BARBS RH ASB MH ACO HE FL has 2 AP RS PY ORAM PHBR (castrin ) RERAR 13 FAME EMG UR ( Carcinoembryonic antigen JPM AMG ZU A COREE IR TL HoT AE AAS BNET AIS (CaF BI AZ BER HH 0% (Di FA SAE ZB 4 pis 2 Heme H CORAL) 2A ¢ icrowytic hypochromic anemia » RH FARM > BRA : WR HER oh (Bites asa oh (te MARE Gy 5 ROR ( Tdiopatiic 1 SM IEALAY AR 47] SAD Ml Prednisolone ~-(HHMPE * DLERMUNER DR » SAK BAM Bt 2.9) at BB Se AG BB EE? WER 1g /KR > ih O~ 128 MH (ERD ng > 2 WA ORME + MHS~ 1 BM HEA 2 melke + HI? MA 6 AMAR E MLA TA EBS : DBL AMTA ro REBOA mst NE BEE TORRMA OES HEM 2~ aE wo wKD@ DOO DODOBG ici Sits 188% Acute graft-versus-host disease) Zasik muh FAH tA aac Jaundice ) Bilirubia EF (BV FIC Diarvnea ) OBA rev (FRA Skin rash ) SEPRR ATEN apps ) MARGE reey HRD > Bie TTA WRADMRRE HR ( O02 delivery > BERHDEDA OL A DORA ER FH 0S FFIGLA ARAN Diuretics ) » TZ PAE ( hyperkalemia) fy pte ? (N2Sm ARAL ( proximal diuretics ) (BIER FIRM ( Loop diuretics ) CMSA FIRM ( Early distal diuretics) DEGMARIN Late distal diuretics ) F Fike te + BAAR Simple goiter Aya ? (Amit , TATE ie Sat 6A SR BB TE CORT ARERR Te DHA DRARKEMZS/ sinple goiter ZRH donee ee 1B 38 nth ie Gt A FE 2 RRR Ooi i Se TR Ie Me Rene » thet TSH annem 2 SaRHRIR FS» TERY TH He Teh BALA BABI Hs PERS» FAB—BSM: ARBRE P RARE F GARR ALE F eats a D) TSH PRAMAS DB lodide AMI RTD RRR ME » ERIE AEE ADAPRRGM RS Rik Be TE BR 73 COMERS Be DEAF RR MRS OR a SECOHD: BEWLL, 25 COHDaDs BEA RTTED F ? eA (Oy Coad AR % een RHEE BL PMS SRB HC BT ONE HE AT Se BZ Ao BULA. © 1 enue wen eat ( Viscosity” > | OME m/e» eh PMN 20% 5 BOTH ES BA (AB (CHE BN BEC OAD (Bate BAD ( Septic arthritis ) Osi MERE HEC Gout ) OVS FEE BEBE (RA) SERRA ( route renal failure ) SHA + AEF IMAM THN AOU Bi ( Peritoneal dialysis) MER 7 WRERLIRE FAC Recent coruoret surgszy (OREREOMRER ( Recent cardiac surgery ) Gehreeteasra Recent abdominal surgery ) IRIE GLBkVIIIS ( severe coagulopathy BRIA DH SMADM > AMER B porydrarion + Rosmorariey ‘300 teosnot ig BE vescopresetAAMIER HE 6 Onnoia lity PAH 200 ownol ke + A ApAytt ( Central or cranial ) RENE Fe Nephrogenic > RIE (ORM Polyainsia ro FFP a He EER FEE ( Acute stoneruionentetore ) GSMS (Co) TRE? (ANG AR EIB RB VERT HE ( Poststreptococcal glomerulonephritis > (Bi'P AY RE RA FERGME (TEA nephropathy ) (0) + WELAAEBEEE ( Goodpasture’s syndrome ) (DG ALIBI UE THLE ERE ( Tdiopatnic rapid progressive glomerulonephritis, RPGN) WARRGIGN (Acute renal failure 9) PARMA? WEEE B® C faminog lycoside 29 | ge: eehee t Nonoligouric ) Ste 38%. GESEERDS MPLAB E RABE CRAB E HBC Mn eR ae eee VERS ELAC HELM FPA MNRD IES Hak » 61S SE A? CACORE AS ESRRRES ES OME (a) AR EGE FE BGA PS OE I LE AE (Chek Wa SHE EH SAAR BU» SFE CB Ae 209% WHR OR LAE HR i UR EEE JEU RNAI ( Diabetic nepnroparhy ) (OeiERSB{C >» FIFI SHR MHL EW 2 WAI ( Qasenent membrance ) SAAT (BI Ximmestiel-Wilson AH CNedule) trad RHE ERB ICC Dittuse glomerilouslerosis > WE MRA ( Leukocyte infiltrs WRAR LE RZ fat OV) + eeieee WR AR@E HAC netrovitus ) CPMIV=-2 EARL A » Se AOsH A v= Braye DNS virus (DH GP 120 ARBRARARMER cha FRR 1) BNR RaeaNiSg, ROARS we emmso% ne Aspe aie 2 as (4 RBEIER AS % DSR BGG (H & Fm)AFZER-RAMNMERRMHAR EG TERRRERORRFRAR ABS O11 RK AL BBO. BMC aD Eh # SIA Re Ga 35 Peas PUK AF REESE I + COURTS SUAS AE BR ME » TF PUDB AGAR SES BRA I a A I WTAE 1B) SE HRD EAP (HF RER 1 Eee EEE ic nctut detiect ree GR FIRM — ann {An CURE 2 $8 OE aR as Ak HEE (C) PB PA 2k DIE ok RAK . 2 -RESOURENC “re--scomnove ppromonpnate scintiaran ) Wer ee Zeer Goma WEEDS ABD A RLM AS (CD ON CLE (Oy FAECAL ESE B & - Interferon (THR 4 gran GG SE SI BRE 2 UF (ont na (OG ARS MA » ee va gins ¢ veatrionte tachycardia Dy Zkih + a ica (ALR FER HIE Te QR S SR (DEF RANE ( A-V dissociation ) (CLK 32 SES ALT HSA (DR RARE 40 Bh RE HS ar (WH LWA adrenaline > IRS ( tosulin > (OBR ( Renin > (BEER PE ( Glucagon ) 4) UR RBIS ED SE + FUT ATER 7 Cov GB JR LA SEED TL PRL (BYH Os i 0 G0 A AN OT SE IE CAP TERM AEG BG See HO MISE R (DIBRE EEME Ae SEF ERIE Ass AO OE a 42K FY A RUPE IRA BR SAS EO 7 INVES RE LPOBA IS » Uf SAFER Be SEM (BRUCE + Us SAH ALE ERE CORBA Ie San BH BES OMS + REET 43 Parinaud’ CO TLA (BURY 1H (C) Accommodation JE Dh} K-FAG# Retraction nystagmus BOWSY Qt LEE ER ORB ¢ MMMM SES ( mitral insutficiency » — (OMPAREE ( Witral stenosis oH $8 frie aggcitoney ) @D)EWIRBRF ( Aortic stenosis ) 4% Pree to Ck ) Fi Wes meMsse hss se RamDimmeaemsit Jie 2 OLR BS NRF 18 Peale + + Lam BES (oi: TPB SEK RA = myc Syl i AHN, ’ A bSER (anette 3 eet (Boi BH) OBR MG (DoE a Vi a0 ee PE HR (vi GRE (8) ADT REM { cholestasis a rma 2 Ws heR mA BR (Ooms det iti ORR BX © FALOERP> ERE LOMA RESON: WTaxeyasu Si @)fenoch-Schén ein Rt (CO Mite BEA ¢ Pelyarcoriets Nodesa > (DiKawasack fy SO HLSEMLAE) BME3 (A-a)Por (AR IEA MBL FA A 2 aarl ORE (ORME O-R-@ st pe RRO e jp Rap aR aD (NLA OF BEES: (2) WG By i AA TR © Fev 1.5 Be (hi FF A BE A 52K PUMR RSA EME MAY ZG AER + BB — FA PTE OO ? INS IENDMB HMEOELC Erythema >» RE ( Swelling } (BE BR 5G FE HEP 2 MS HE ORARDME CABUEBE ASSAM FER ORAM ABA—NE 53 BRU SSE F SUE — BA SE te AG AE EO HD (Familial spoprotein C11 deficiency (B)Familial hypercholesterolemia () Familial hypertriglyceridemia @)Familial type 3 hyperlipoproteinemia MHRA LG + PRE Fiaa + C vepitide Ph» (8 proinsulin RES + FA anne oa: (on dy sei tonyiures owe ie TE aman? FR ee ee ic cecant £ MEME ER REM — AS MOAR ACGM SH DERE Ce 0s She PAR DALE Mia FAB GL BBLS GCA O31014a 28 ® ewseses ie J5 88 a 2 AesaeRE URRALTRER - FAART ERR BER? RETA = COMER RNIN mg tes sere HEMGCUE ¢ gona1 taneier vostosie EMO RERRZIT ? A) Sgogren ERE WHEAEEE ( Seleroderma ) (ORM Doreatoayositie ) De LSE ( Systemic lupus erythomatosus ) HRROME ( typermalonis » TURE AEH REEEOE ARORA RURMAE SRE ORDDS mols RLEPREK: QRSKkAABHEGANE CORSE TERMS OE OBAMAS ( insulin Re VEHEA MBA MULE (Spicer angioma.) BALE TAIOTEEAR ORS (CREA MRT PRBS Bla Rem : (03S Hz SLE (H36~70 Hz (C)75~ 105 Hz 140 He bE WekmmoeR Re eU ame C sitereak (DMA sn Ken : a outbreak RRM WHINC Sickle cell sacaia ) BAS BRR AAMT EA KI OAR OREM BR ae Te Es i aR A BS I eB BERN (als Sa ABE 2: ah Ha AEE He EATS Lite 7 AB DFM (BC BATHS HE ODUFRAW DE MBER GE Tamoxifen citrate 34 Pili (Me & SRF 7 Am FRE eng Ons OILS eeroue selerosis SEWER : RE a CARMA RE —BES OBA Adenoma sebaceun Fipahemesna: Screening program ) MRDHECR? (me CRF ORE Papaya Addison's disease zm A (Ah OP HBB HE (BD itt & 239 on ADIL » Ok oe eet ( Repolarization) 2” mn WOR SHAK WS TMA CST segment) OTH OSTMARARTH BA FARR OSG + ZaReGTRESE RE ARDS) W 0s {@ Ozone @ 0, ARE PIER ( Acute renal failure ) RBS, Lo RPS Hi? (ABR BBR (BREE A IRE CORREA Oh tea OV GREARIE AGE ( Acromogaly ) BARON M A Woctreotiae () Brosocriptine (C)Dibenzyline _(O) Cyproheptadine HGOLR Dew A TAR: ld) Steroid hormone @Pyridostigmine — () Neouycin —{pBphedrine BM es kx ( Septic shock ) (RAE POG» ARG MARA THM TREES A) GBBT ( Hemodialysis ) (BARGAWET ( Peritoneal dialysis ) (CBU MBH BWA (Continuous arteric-venous henofiltration, CAVH ) (Obi EA ( Henopertusion eee es Bi Reliot: hy GEM Dermatomyositis) APES OAR R ROE? (OME BLE ( Scleroderma } aE a > "4 AEN HERE 2 cy - daiteageagome: a (ORI UE PLS AOE a Rt (OVER FF LHS OLE iT % SIAgERER HHL RERRS BBR ARG TIER TH ALGO RESIS AS ME » PRCA TAM EBERS Wie CA AUK A RAR RIE R > BHABHA fe + TSE pene ik WOR tavyem ( uinimal change disease ) (BR ANEAIRIRL( Focal glonerulosclerosis ) (CBE FGM ( Nembranous nephropathy ) (OBE 4 FE ERR HF (Mombranoproliterative glomerulonephritis ) B LU RBRMS RATERS R ¢ aGephalosporin > Cefuroxine @ lmipenen (D) Sztreonsn BD fagecenenene BAL (CF RAR DBR o auSciees RRO Ea DOTA? VAY: BB VANE (ORME ave OBST. Lave